RxDoctor Payments Data

John Lutz, MD

Interventional Pain Medicine · Jackson, MSNPI 1255628020

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $3,715 of the $4,542 with a category attached, or 81.8%. Boston Scientific accounts for 68.5% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2022 at $2,032 and has fallen 77.1% since, to $466 in 2025.

$4,542in general payments, 2019–2025

Across 103 payments — averaging $44.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$3K
  • Abbott$661
  • Medtronic$399
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$136
  • SPR Therapeutics, Inc$68
  • Nalu Medical, Inc.$61
  • plus $106 from 5 others

What the payments were for

  • Travel & lodging$82818%
  • Food & beverage$3,71582%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,542 in reported general payments places this provider in the 70th percentile of 24 interventional pain medicine providers in Mississippi.

See all interventional pain medicine providers in Mississippi

Medicare billing

Part B allowed, 2024
$231,367
Medicare patients
485
Services billed
3,949

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin191$5,340
Gabapentin353$2,848
Diclofenac Sodium252$2,659
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen152$2,305
Methocarbamol240$1,983
Tramadol Hcl197$1,031
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen32$864
Meloxicam312$790
Cyclobenzaprine Hcl111$767
Tizanidine Hcl61$559
Diclofenac Potassium23$376
Nortriptyline Hcl39$189
Methylprednisolone25$140
Mupirocin14$109
Baclofen15$86

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in Jackson

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →